Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,637-9,648 of 10,661

Drug study icon

CompletedNCT04199468

THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Other study type icon

CompletedNCT04429568

THC Crossover Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherOver 21 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Addiction

Device study icon

CompletedNCT03080168

The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityDeviceOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Suicidality

Other study type icon

CompletedNCT01637415

The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalOver 18 Years

Countries: United States
Sponsor: Stanford University
Condition: Addiction

Behavioral study icon

CompletedNCT06014892

The 4th Trimester Initiative: The Impact of Parental Support on Pregnant Trainee Wellbeing

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioral

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Depression

Behavioral study icon

CompletedNCT04068142

The Acceptability and Feasibility of an ED-based, Peer-delivered, Suicide Safety Planning Intervention

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralFrom 18 Years to 89 Years

Countries: United States
Sponsor: University of Arkansas
Condition: Suicidality

Device study icon

CompletedNCT06543355

The Acupuncture for Pain, Addiction and Mood

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDeviceOver 18 Years

Countries: United States
Sponsor: Albert Einstein College of Medicine
Condition: Addiction

Behavioral study icon

CompletedNCT04925570

The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Woebot Health
Condition: Addiction

Drug study icon

TerminatedNCT00369915

The Antidepressant Efficacy of the Anticholinergic Scopolamine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression, Bipolarity

Behavioral study icon

CompletedNCT03050853

The Appeal and Impact of E-cigarettes in Smokers With SMI

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityBehavioralOver 18 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Bipolarity

Drug study icon

CompletedNCT00044187

The Assessment of a Weight-Gain Agent for Olanzapine-Associated Anti-Obesity Agent in people with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolarity type I

This study is completed in the United States. It focuses on schizophrenia.

In United States

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: Bipolarity, Schizophrenia

Other study type icon

CompletedNCT01467089

The Assessment of Movement Disorders Utilizing Live Two-Way Video

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 18 Years to 75 Years

Countries: United States
Sponsor: Northwell Health
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.